Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients

• Published in: Tumour virus research Vol. 14; p. 200249
• Main Authors: Hassan, Marwa, Attia, Mohammed Saad, Ali-Eldin, Zainab, El Attar, Gamal, Elzallat, Mohamed, Saad, Hany Haroun Kaisar, Isaac, Amira
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier 01.12.2022
• Subjects: B7-H1 Antigen - genetics; Biomarkers; Carcinoma, Hepatocellular - genetics; Egypt; Full Length; Gene polymorphism; Genetic Predisposition to Disease; Hepacivirus - genetics; Hepatitis C - complications; Hepatitis C virus; Hepatocellular carcinoma; Humans; Liver cirrhosis; Liver Cirrhosis - genetics; Liver Neoplasms - genetics; Polymorphism, Single Nucleotide; Programmed death-ligand 1; Egypt; Hepatocellular carcinoma; Programmed death-ligand 1; Hepatitis C virus; Gene polymorphism; Liver cirrhosis
• ISSN: 2666-6790; 2666-6790
• DOI: 10.1016/j.tvr.2022.200249

Considering the immune evasion role of programmed death-ligand 1 (PD-L1) in cancer development, its genomic variations might be closely associated with disease development and cancer risks. Accordingly, this study was performed to investigate how the PD-L1 gene polymorphisms affect the susceptibility to hepatitis C virus (HCV)-induced liver cirrhosis and cancer development in the Egyptian population. Two single nucleotide polymorphisms of the PD-L1 gene; rs2297136 (A > G) and rs4143815 (C > G), were studied in 50 HCV, 51 liver cirrhosis, and 52 hepatocellular carcinoma (HCC) patients as well as 50 healthy subjects using real-time PCR. The frequencies of PD-L1 rs2297136 AA and rs4143815 GG genotypes were significantly higher in the liver cirrhosis than the control and HCV groups. The rs4143815 CG and GG genotypes were linked to a higher risk of developing HCC and were positively associated with the clinicopathological features of HCC. The PD-L1 rs2297136 AA and rs4143815 GG genotypes increase the susceptibility to liver cirrhosis. The rs4143815 CG and GG genotypes are positively associated with HCC risk and its clinicopathological characteristics. Therefore, HCV patients carrying the PD-L1 rs4143815 G-allele should be followed up on a regular basis to allow for early HCC management.